Omnichannel

In our experience, Medical Omnichannel is one of the most over-hyped and under-delivered strategies in the biopharma industry.

Many companies invest heavily in digital platforms, content management systems and engagement tools, only to find that their Medical Omnichannel strategy fails to deliver meaningful engagement with healthcare professionals.

The problem is rarely the technology. More often, it's a failure to define what success looks like and how to measure it.

At LUCENT, we believe that effective Medical Omnichannel strategy requires three types of measures:

Input Measures: These track the resources and activities being deployed - content creation, channel selection, frequency of engagement and reach. Without input measures, you cannot assess whether you have the right infrastructure in place.

Lead Measures: These track the immediate outputs of your activities - HCP engagement rates, content consumption, event attendance and digital interaction metrics. Lead measures tell you whether your strategy is resonating with your audience.

Outcome Measures: These track the ultimate impact on healthcare practice and patient outcomes - changes in prescribing behaviour, adoption of clinical guidelines and patient access to new medicines. Outcome measures are the true test of whether your Medical Omnichannel strategy is driving meaningful change.

Most companies focus heavily on input measures and occasionally track lead measures. Very few systematically measure outcomes. This creates a dangerous illusion of progress - lots of activity, lots of engagement, but little evidence of impact.

At LUCENT, we help organisations design and implement measurement frameworks that connect inputs to outcomes, ensuring that Medical Omnichannel investments deliver genuine strategic value.